Back to Search Start Over

Monoclonal Gammopathy of Renal Significance and Thrombotic Microangiopathy: A Case Report.

Authors :
Ventura S
Cabral R
Viveiros C
S Santos M
Esteves J
Source :
Cureus [Cureus] 2022 Dec 20; Vol. 14 (12), pp. e32753. Date of Electronic Publication: 2022 Dec 20 (Print Publication: 2022).
Publication Year :
2022

Abstract

Monoclonal gammopathy of renal significance (MGRS) is a group of pathologies that includes all kidney disorders related to a monoclonal protein in patients without diagnostic criteria for B-cell malignancies. There are multiple MGRS-associated kidney disorders, and more are still being discovered, which makes this diagnosis challenging. The relationship between monoclonal gammopathies and thrombotic microangiopathy (TMA) is of growing interest in literature. This article describes the case of a patient with newly diagnosed MGRS, presenting with rapidly progressing kidney failure and with histologic characteristics of TMA. The patient progressed to end-stage renal disease (ESRD) despite treatment with plasmapheresis and clone-directed therapy, as is currently advised in the literature. Although rare, the association between these two entities should not be unnoticed because of patients' renal and vital prognosis.<br />Competing Interests: The authors have declared that no competing interests exist.<br /> (Copyright © 2022, Ventura et al.)

Details

Language :
English
ISSN :
2168-8184
Volume :
14
Issue :
12
Database :
MEDLINE
Journal :
Cureus
Publication Type :
Report
Accession number :
36686103
Full Text :
https://doi.org/10.7759/cureus.32753